Jaguar Health, Inc. (JAGX)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$10.1M
Cash & Equivalents
$8.8M
Quarterly Burn Rate
$11M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05064540 JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization OTHER Recruiting 450

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-06-25 8-K Jaguar Health, Inc. (JAGX) (CIK 0001585608) - EX-99.1 EDGAR
2026-06-22 8-K/A Jaguar Health, Inc. (JAGX) (CIK 0001585608) - EX-99.1 EDGAR
2026-06-22 8-K Jaguar Health, Inc. (JAGX) (CIK 0001585608) - 8-K EDGAR

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for JAGX.

SEC EDGAR Filings

All SEC filings for Jaguar Health, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.